These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of desmopressin (DDAVP) in controlling aspirin-induced coagulopathy after cardiac surgery. Kam PC Heart Lung; 1994; 23(4):333-6. PubMed ID: 7960860 [TBL] [Abstract][Full Text] [Related]
24. Myocardial infarction in a patient with hemophilia treated with DDAVP. Bond L; Bevan D N Engl J Med; 1988 Jan; 318(2):121. PubMed ID: 3336392 [No Abstract] [Full Text] [Related]
25. [Thrombogenic risk of DDAVP in chronic renal insufficiency]. Viron B; Michel C; Serrato T; Verdy E Nephrologie; 1987; 8(4):225. PubMed ID: 3696372 [No Abstract] [Full Text] [Related]
26. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490 [TBL] [Abstract][Full Text] [Related]
27. Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease. Lusher JM Haemostasis; 1994; 24(5):276-84. PubMed ID: 7843638 [TBL] [Abstract][Full Text] [Related]
28. DDAVP-associated hyponatremia. Delfanian K; Zawada ET S D J Med; 2001 Jul; 54(7):255-6. PubMed ID: 11471328 [TBL] [Abstract][Full Text] [Related]
31. [The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)]. Blättler W; Jacky E; Müller M; Graf M; Meili E Ther Umsch; 1979 Apr; 36(4):330-3. PubMed ID: 377557 [No Abstract] [Full Text] [Related]
32. Life threatening biphasic adverse reactions to desmopressin: case report and review of the literature. Wang L; Chen R; Tian F; Wang W; Wang L; Yu B; Huang X; Zhang Y; Su S; Ma G; Wang K Int J Clin Pharmacol Ther; 2016 Aug; 54(8):640-4. PubMed ID: 27142268 [TBL] [Abstract][Full Text] [Related]
33. Effect of 1-deamino 8-D-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis. Akoğlu E; Görür S; Atik E; Okuyucu S; Sangün O Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1919-22. PubMed ID: 16901550 [TBL] [Abstract][Full Text] [Related]
34. Treating desmopressin-induced hyponatremia: a case using hypertonic saline. Shirazian S; Ali N; Fishbane S Clin Nephrol; 2013 Nov; 80(5):385-7. PubMed ID: 22579272 [TBL] [Abstract][Full Text] [Related]
35. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus]. Radó J; Pató E Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810 [No Abstract] [Full Text] [Related]
36. Hyponatraemia and cerebral convulsion after a single dose of intranasal DDAVP. Neuhaus TJ; von der Heiden-Ranz M Pediatr Nephrol; 1997 Aug; 11(4):527. PubMed ID: 9260262 [No Abstract] [Full Text] [Related]
37. DDAVP for von Willebrand menorrhagia--severe hyponatraemia, haemolysis, seizure, coma.!! Caution. Olowokure O; Fishman M; Cromwell C; Aledort L Haemophilia; 2009 May; 15(3):837. PubMed ID: 19432930 [No Abstract] [Full Text] [Related]
38. Diminishing blood loss during operation for burns. Haith LR; Patton ML; Goldman WT; McCutchan KM Surg Gynecol Obstet; 1993 Feb; 176(2):119-23. PubMed ID: 8421798 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness, specificity and safety of intranasal 1-deamino-8-D-arginine vasopressin treatment of normal blood donors. Palmer DS; Harris AS; Tittley P; Rock G Haemostasis; 1988; 18(3):187-96. PubMed ID: 2972594 [TBL] [Abstract][Full Text] [Related]
40. Current status of non-transfusional haemostatic agents. Cattaneo M; Mannucci PM Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]